MUNICH — Statin therapy cut risk for major adverse CV events by 30% for healthy older adults compared with placebo, but did not extend disability-free survival, according to data presented at the European Society of Cardiology Congress.The benefits and risks of initiating statin therapy are not as clear among older adults without previous CV events and evidence is particularly sparse for

STAREE trial will give its verdict on primary prevention statins in people ages 70 and up

MUNICH — Statin therapy cut risk for major adverse CV events by 30% for healthy older adults compared with placebo, but did not extend disability-free survival, according to data…